References
- Adams MA, Bobik A, Korner PI. (1989). Differential development of vascular and hypertension in genetic hypertension. Hypertension 14:191–201
- Aneas I, Rodrigues MV, Pauletti BA, Silva GJ, Carmona R, Cardoso L, Kwitek AE, et al. (2009). Congenic strains provide evidence that four mapped loci in chromosomes 2, 4, and 16 influence hypertension in the SHR. Physiol Genomics 37:52–7
- Chan SH, Wu KL, Chang AY, Tai MH, Chan JY. (2009). Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 53:217–27
- Cicila GT, Morgan EE, Lee SJ, Farms P, Yerga-Woolwine S, Toland EJ, Ramdath RS, et al. (2009). Epistatic genetic determinants of blood pressure and mortality in a salt-sensitive hypertension model. Hypertension 53:725–32
- McGuire PG, Tweitmeyer TA. (1985). Aortic endothelial functions in developing hypertension. Hypertension 7:483–90
- Thomas SR, Witting PK, Drummond GR. (2008). Redox control of endothelial function and dysfunction: Molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10:1713–65
- Weindruch R. (1995). Animal models. In: Masoro EJ, editors. Handbook of physiology, section 11: Aging. New York, Oxford: Oxford University Press. p 37–52